Announcing the partnership between Ster-Pharma Control (NL) and Genano (FI) in the field of cleanroom bio-decontamination services for the Pharma, MedTech, and IVD sectors. The integration of Genano technology’s advanced air decontamination systems with Ster-Pharma Control’s iHP bio-decontamination services will enhance the ability to both achieve and maintain the stringent cleanliness standards required in pharmaceutical production.
Cleanrooms are essential in the pharmaceutical, Medical Technology (MedTech), and IVD production industry as they maintain a controlled environment free from contaminants that could compromise the quality of a wide variety of products produced in cleanrooms. Genano’s technology is known for its unique ability to eliminate 99.999% of microbes from indoor air, including nano-sized particles that traditional HEPA filters may not capture. This level of decontamination is crucial for areas where high air hygiene is required, such as in the production of sterile medications, Class III medical devices, IVD production facilities, and bio-research laboratories, ensuring the safety and efficacy of products produced in them.
The partnership is expected to provide a host of benefits, including improved ISO-class environments, reduced risk of contamination, and enhanced protection for both products and personnel. For instance, healthcare facilities have reported significant reductions in surgical site infections when using Genano’s air purifiers, highlighting the potential for similar outcomes in other cleanroom settings.
“This is part of a strategy for Ster-Pharma Control to offer innovative products in the bio-decontamination space and to continue to grow its product portfolio alongside its growing services offering to pharma and the MedTech / IVD sectors,” says Dr. Dale Charlton, Head of Business Development from Ster-Pharma Control. For Ster-Pharma Control, this partnership with the Genano technology represents a commitment to delivering the highest standards of cleanroom decontamination services. Moreover, the collaboration aligns with the growing trend of strategic partnerships in the decontamination of cleanrooms sector, where innovative technology plays a pivotal role in advancing healthcare solutions. As the industry continues to evolve, such partnerships are becoming increasingly important for driving innovation and maintaining competitive edges for users.
For more detailed information on Ster-Pharma Control’s Bio-decontamination Services & Genano’s air decontamination technology and their applications in healthcare and laboratory settings, you can visit their respective official websites: Ster-Pharma Control and Genano, or contact us directly by e-mail at info@ster-pharmacontrol.com for more information.